The prognostic effect of sTIL on OS is reduced when considering pCR in our series, which is similar to what has been described in the general breast cancer population (28), a trend could be observed for improved DFS and OS with increasing sTIL, even in the ER+/HER2− subgroups. This evidence concerns the gene ESR1 and breast cancer.